POSLUMA
NDC 69932-002, flotufolastat F-18, injection, from Blue Earth Diagnostics.
- Product NDC
- 69932-002
- Status
- Listed
- Labeler
- Blue Earth Diagnostics
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216023
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69932-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLOTUFOLASTAT F-18158 mCi/mL
Pharmacologic classes
Positron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69932-002-50 | 69932000250 | 25 mL in 1 VIAL, MULTI-DOSE (69932-002-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/907ac4a4-a088-4826-ab50-cfc31985c9d4
Use it
Look up 69932-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69932-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69932-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.